EVE Health Group Ltd
EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003… Read more
EVE Health Group Ltd (EVEDA) - Total Assets
Latest total assets as of June 2024: AU$2.52 Million AUD
Based on the latest financial reports, EVE Health Group Ltd (EVEDA) holds total assets worth AU$2.52 Million AUD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EVE Health Group Ltd - Total Assets Trend (2021–2024)
This chart illustrates how EVE Health Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
EVE Health Group Ltd - Asset Composition Analysis
Current Asset Composition (June 2024)
EVE Health Group Ltd's total assets of AU$2.52 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 4.2% |
| Accounts Receivable | AU$1.35K | 0.1% |
| Inventory | AU$141.53K | 5.6% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how EVE Health Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EVE Health Group Ltd's current assets represent 100.0% of total assets in 2024, an increase from 39.4% in 2021.
- Cash Position: Cash and equivalents constituted 4.2% of total assets in 2024, down from 26.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 5.6% of total assets.
EVE Health Group Ltd Competitors by Total Assets
Key competitors of EVE Health Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
EVE Health Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - EVE Health Group Ltd generates 0.85x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - EVE Health Group Ltd is currently not profitable relative to its asset base.
EVE Health Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | - | - |
| Quick Ratio | 1.83 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | AU$1.22 Million | - | - |
EVE Health Group Ltd - Advanced Valuation Insights
This section examines the relationship between EVE Health Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 27.08 |
| Asset Growth Rate (YoY) | -39.0% |
| Total Assets | AU$2.52 Million |
| Market Capitalization | $68.31 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values EVE Health Group Ltd's assets at a significant premium ( 27.08x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: EVE Health Group Ltd's assets decreased by 39.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for EVE Health Group Ltd (2021–2024)
The table below shows the annual total assets of EVE Health Group Ltd from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | AU$2.52 Million | -38.97% |
| 2023-06-30 | AU$4.13 Million | -48.79% |
| 2022-06-30 | AU$8.07 Million | -32.30% |
| 2021-06-30 | AU$11.92 Million | -- |